esqLABS
Software, Consulting and Workshops for Data Analysis and Model-Based Decision Support
GlobalData analysed the number of clinical trials of both industry and non-industry-sponsored trials with start dates between January 2019 and December 2019.
GlobalData analysed the number of clinical trials of both industry and non-industry-sponsored trials with start dates between January 2019 and December 2019.
GlobalData analysed trials with industry and non-industry sponsors. Figure 1 shows that overall non-industry sponsors conducted more trials than industry sponsors in 2019. Industry sponsors conducted the highest percentage of trials in Q4 at 46.9%, whereas non-industry sponsors had the highest percentage of trials in Q1 at 67.6%.
After further analysis, Novartis had conducted the highest amount of trials in 2019 for an industry sponsor, whereas Cairo University had conducted the most amount of trials for a non-industry sponsor. Industry-sponsored trials were the lowest in Q3 at 32.9% and non-industry-sponsored trials were the lowest in Q4 at 53.1%. Overall the US had conducted the highest amount of trials for 2019, followed by China.
Latest report from
Browse over 50,000 other reports on our store.
Visit GlobalData Store
Software, Consulting and Workshops for Data Analysis and Model-Based Decision Support
Customised Clinical Supply and Biological Sample Services
Nanofibre and Nanoparticle Production Systems